A Loughborough University student has developed a new medical device that could transform how prostate health is assessed and monitored. Subscribe to our newsletter for the latest sci-tech news ...

The raise will support Rivermark’s pivotal trial, while allowing the medtech company to ready its FloStent system for ...

Olympus has signed a definitive agreement to acquire BioProtect for $270 million, adding biodegradable balloon spacer ...

BioProtect’s lead product is a spacer system designed to protect healthy tissues during radiation therapies for prostate ...

Butterfly Medical announced today that it completed its Series C funding round, bringing in $21 million to support its BPH ...

Less than a week after making a regulatory submission for a $1 million capital raise, prostate health company ProUroCare Medical, based in Eden Prairie, Minnesota, announced that it has secured market ...

The US Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) issued draft guidance Tuesday to support clinical testing of high-intensity ultrasound systems for ...

Transrectal ultrasound guided (TRUS) biopsy has been the gold standard for prostate cancer diagnosis, but carries a significant risk of urinary tract infection, sometimes requiring hospital admission ...

ProUroCare Medical, Inc., of Minneapolis, Minn., has filed a de novo application with the FDA seeking marketing clearance for its prostate mechanical imaging (PMI) device (ProUroScan). This will allow ...

Industry trade associations made the case for revisions to draft guidance on clinical testing recommendations for prostate tissue ablation devices in comments earlier this month. The Medical Imaging & ...

Clinical studies of Dr Allen’s US Patented Thermobalancing Therapy in men with benign prostatic hyperplasia or benign prostatic enlargement (BPE or BPH) have demonstrated the efficacy and safety of ...